Leveraging In Vitro, In Vivo, & In Silico Tools to Recapitulate Genetic & Non-Genetic Renal Disorders
Time: 2:01 pm
day: Workshop C
Details:
- Following guidance that the FDA no longer requires animal models for drug development, what preclinical approaches are being harnessed to study rare and genetic kidney diseases?
- Exploring tissue-bioengineering approaches for modelling rare kidney diseases
- Understanding considerations for preclinical investigation of rare and genetic kidney diseases
- Applying computational tools alongside preclinical modelling to mitigate preclinical development risk
